Arcutis Biotherapeutics Stock News & Updates
[WKN: A2PYWE | Symbol: ARQT]
Arcutis Biotherapeutics
Arcutis Biotherapeutics – 59% Growth and ZORYVE Market Share Gains
Arcutis Biotherapeutics: Promising Biotech Upstart in Dermatological Therapy
Arcutis' value is almost entirely based on the approved non-steroidal medication ZORYVE® (Roflumilast),...
Arcutis Biotherapeutics: Cortisone-Free Ointment ZORYVE as a new Alternative for Eczema
Rapid Revenue Increase: ZORYVE is growing with +471% revenue in 2024 and establishing itself as an alternative...
- ‹
- 1
- ›